Mydecine will restate 2022 financials, lowering cash levels even further
Mydecine Innovations Group Inc. (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) will restate its previously filed audited financial statements for the fiscal year ended Dec. 31, 2022. Mydecine said the change…
